Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elham Gholami

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Expert Review of Vaccines|February 25, 2016
Delivery systems for Leishmania vaccine developmentElham Gholami, Farnaz Zahedifard, Sima Rafati
Experimental Parasitology|December 29, 2010
Evaluation of DNA/DNA and prime-boost vaccination using LPG3 against Leishmania major infection in susceptible BALB/c mice and its antigenic properties in human leishmaniasisNarges Abdian, Elham Gholami, Farnaz Zahedifard, et al.
Parasites & Vectors|October 19, 2022
Structural analysis of PpSP15 and PsSP9 sand fly salivary proteins designed with a self-cleavable linker as a live vaccine candidate against cutaneous leishmaniasisMahya Sadat Lajevardi, Tahereh Taheri, Elham Gholami, et al.
Experimental Parasitology|April 27, 2010
Leishmania major: disruption of signal peptidase type I and its consequences on survival, growth and infectivityTahereh Taheri, Ali-Hatef Salmanian, Elham Gholami, et al.
Iranian Biomedical Journal|January 19, 2020
Visualization of Leishmania tropica Infection in BALB/c Mice by Bioluminescence ImagingMahdieh Eskandar, Elham Gholami, Negar Seyed, et al.
Vaccine|March 31, 2007
Leishmania major heat shock protein 70 (HSP70) is not protective in murine models of cutaneous leishmaniasis and stimulates strong humoral responses in cutaneous and visceral leishmaniasis patientsSima Rafati, Elham Gholami, Nafiseh Hassani, et al.
Biomaterials Science|February 19, 2021
Nano-adjuvant based on silk fibroin for the delivery of recombinant hepatitis B surface antigenFatemeh Rezaei, Hamid Keshvari, Mohammad Ali Shokrgozar, et al.
Vaccines|October 27, 2022
Antibiotic-Free Nanoplasmids as Promising Alternatives for Conventional DNA VectorsNegar Seyed, Farnaz Zahedifard, Sima Habibzadeh, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|November 25, 2010
Cationic solid lipid nanoparticles loaded by cysteine proteinase genes as a novel anti-leishmaniasis DNA vaccine delivery system: characterization and in vitro evaluationsDelaram Doroud, Alireza Vatanara, Farnaz Zahedifard, et al.
Scientific Reports|May 20, 2026
Bulky pcDNA plasmid encoding Leishmania- and Sandfly-derived antigens resulted in transient Th1 response post Leishmania major infection in BALB/c miceNegar Seyed, Hamzeh Sarvnaz, Sima Habibzadeh, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Expert Review of Vaccines|February 25, 2016
Delivery systems for Leishmania vaccine developmentElham Gholami, Farnaz Zahedifard, Sima Rafati
Experimental Parasitology|December 29, 2010
Evaluation of DNA/DNA and prime-boost vaccination using LPG3 against Leishmania major infection in susceptible BALB/c mice and its antigenic properties in human leishmaniasisNarges Abdian, Elham Gholami, Farnaz Zahedifard, et al.
Parasites & Vectors|October 19, 2022
Structural analysis of PpSP15 and PsSP9 sand fly salivary proteins designed with a self-cleavable linker as a live vaccine candidate against cutaneous leishmaniasisMahya Sadat Lajevardi, Tahereh Taheri, Elham Gholami, et al.
Experimental Parasitology|April 27, 2010
Leishmania major: disruption of signal peptidase type I and its consequences on survival, growth and infectivityTahereh Taheri, Ali-Hatef Salmanian, Elham Gholami, et al.
Iranian Biomedical Journal|January 19, 2020
Visualization of Leishmania tropica Infection in BALB/c Mice by Bioluminescence ImagingMahdieh Eskandar, Elham Gholami, Negar Seyed, et al.
Vaccine|March 31, 2007
Leishmania major heat shock protein 70 (HSP70) is not protective in murine models of cutaneous leishmaniasis and stimulates strong humoral responses in cutaneous and visceral leishmaniasis patientsSima Rafati, Elham Gholami, Nafiseh Hassani, et al.
Biomaterials Science|February 19, 2021
Nano-adjuvant based on silk fibroin for the delivery of recombinant hepatitis B surface antigenFatemeh Rezaei, Hamid Keshvari, Mohammad Ali Shokrgozar, et al.
Vaccines|October 27, 2022
Antibiotic-Free Nanoplasmids as Promising Alternatives for Conventional DNA VectorsNegar Seyed, Farnaz Zahedifard, Sima Habibzadeh, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|November 25, 2010
Cationic solid lipid nanoparticles loaded by cysteine proteinase genes as a novel anti-leishmaniasis DNA vaccine delivery system: characterization and in vitro evaluationsDelaram Doroud, Alireza Vatanara, Farnaz Zahedifard, et al.
Scientific Reports|May 20, 2026
Bulky pcDNA plasmid encoding Leishmania- and Sandfly-derived antigens resulted in transient Th1 response post Leishmania major infection in BALB/c miceNegar Seyed, Hamzeh Sarvnaz, Sima Habibzadeh, et al.
Pageof 3